• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Assessing FIGS (FIGS) Valuation After Recent Share Price Volatility

    Simply Wall St·02/14/2026 05:29:34
    Listen to the news

    FIGS (FIGS) has drawn attention after recent share price swings, with a 17% decline over the past month contrasting with an 11% gain over the past 3 months and an 86% total return over the past year.

    See our latest analysis for FIGS.

    The recent 16.7% 30 day share price return decline has cooled some of the strong 1 year total shareholder return of 86.4%. This suggests momentum has paused after a solid run and may now reflect shifting expectations around growth and risk.

    If FIGS has you rethinking where the next opportunity might come from, it could be worth scanning our list of 23 top founder-led companies as a fresh starting point.

    With FIGS shares recently cooling after a strong 1 year run, the key question now is whether the current US$10.25 price reflects its growth potential or if the market has already priced in future gains.

    Most Popular Narrative: 42.2% Overvalued

    According to a widely followed narrative by julio, FIGS' fair value is set at $7.21 using a 9% discount rate, compared with the recent $10.25 share price.

    FIGS concentrates on a specific niche within the healthcare industry , medical professionals. The company sells primary apparel, as well as related products. By catering to the unique needs and preferences of this market segment, FIGS tailors its products to precisely match their requirements. This has allowed the company to develop a brand synonymous with this segment, improving its competitive positioning.

    Read the complete narrative.

    Want to understand why a focused brand and premium positioning still lead to a lower fair value than today’s price, even with growth and margin expansion assumptions baked in? The narrative leans on expanding categories, new geographies and a richer product mix to justify its cash flow outlook. It also bakes in a profit profile and future earnings multiple that many investors usually reserve for higher growth stories. Curious how those moving pieces combine to reach $7.21 instead of $10.25? The full narrative connects each of those assumptions step by step so you can judge them for yourself.

    Result: Fair Value of $7.21 (OVERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, this view could unravel if margin progress stalls or if premium pricing meets resistance from healthcare buyers, who are facing tighter budgets and shifting priorities.

    Find out about the key risks to this FIGS narrative.

    Build Your Own FIGS Narrative

    If you see the numbers differently or prefer testing your own assumptions, you can build a FIGS view in just a few minutes by starting with Do it your way.

    A good starting point is our analysis highlighting 2 key rewards investors are optimistic about regarding FIGS.

    Looking for more investment ideas?

    Once you have a view on FIGS, do not stop there, the screener can help you quickly spot other potential opportunities that match your style.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.